Implementing Updated Intraamniotic Infection Guidelines at a Large Academic Medical Center
Open Access
- 30 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (9) , ofae475
Abstract
Intraamniotic infection (IAI) affects 2-5% of pregnancies, causing significant neonatal and maternal morbidity. The American College of Obstetrics and Gynecology suggests ampicillin and gentamicin as first line IAI treatment. Due to potential drug toxicity, changes in gentamicin susceptibility cutoff points, and rising Enterobacterales gentamicin and ampicillin resistance, changes in IAI antibiotic treatment were implemented at Vanderbilt University Medical Center. Combination ampicillin, gentamicin and clindamycin were replaced by piperacillin-tazobactam in institutional IAI treatment. Implementation strategies included repeated education sessions to gain stakeholder trust and buy-in and changing pre-existing electronic clinical decision support tools (eCDST) to default selection of piperacillin/tazobactam, capitalizing on highly reliable intervention strategies of forcing function and automatization/computerization. Change in antibiotic use, measured in days of therapy (DOT)/1000 patient days present (1000PDP) by week initiated, before and after eCDST changes was analyzed with interrupted time series analysis. Effects on hospital length of stay, repeat antibiotics within 14 days, and 30-day readmission were evaluated using multivariable linear and logistic regression. After updated eCDST go-live, piperacillin-tazobactam use increased by 1.9 DOT/1000PDP (95% Confidence Interval (CI) 0.7, 3.1) by week initiated and ampicillin, gentamicin, and clindamycin use decreased by -2.5 DOT/1000PDP (95% CI -3.8, -1.2) by week initiated. Hospital length of stay, repeat antibiotics within 14 days, and 30-day readmission rate did not significantly change. Forced function changes to existing eCDSTs, supported by stakeholder education, successfully changed IAI empiric antibiotic use without unintended patient safety consequences.Keywords
This publication has 24 references indexed in Scilit:
- Quality-in-use characteristics for clinical decision support system assessmentComputer Methods and Programs in Biomedicine, 2021
- Antibiotic stewardship based on education: minor impact on knowledge, perception and attitudeInfectious Diseases, 2019
- Clinical Decision Support Systems and Their Role in Antibiotic Stewardship: a Systematic ReviewCurrent Infectious Disease Reports, 2019
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Serum Creatinine in Pregnancy: A Systematic ReviewKidney International Reports, 2019
- Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research AgendaAdministration and Policy in Mental Health and Mental Health Services Research, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Back to the Future: Using Aminoglycosides Again and How to Dose Them OptimallyClinical Infectious Diseases, 2007
- Aminoglycoside resistance in gram-negative bacilli during increased amikacin useThe American Journal of Medicine, 1985
- Progressive Increase in Antibiotic Resistance of Gram-negative Bacterial IsolatesArchives of internal medicine (1960), 1983